29.07Average Price Target
The highest estimate is 55.00.
From 15 ratings within the last 6 months. This is not an investment recommendation.
This list is based on the watchlists of people on Stock Events who follow TNDM. It's not an investment recommendation.
This list is an analysis based on recent market events. It's not an investment recommendation.
Tandem Diabetes Care, Inc., a medical technology firm, specializes in creating, developing, and marketing solutions for individuals globally who manage insulin-dependent diabetes. At the core of its offerings is the t:slim X2 insulin delivery system, an advanced pump platform that integrates the t:slim X2 pump, a disposable 300-unit insulin cartridge, and an infusion set. Tandem further enhances this platform with innovative features like Basal-IQ and Control-IQ technology, as well as G5 Integration capabilities. The company also provides the Tandem Device Updater, enabling users to easily update their pump's software. To facilitate therapy management, Tandem offers t:connect, a web-based application that visually presents diabetes data from the pump, continuous glucose monitoring (CGM) devices, and supported blood glucose meters to patients, their caregivers, and healthcare professionals. Additionally, the Sugarmate mobile application caters specifically to insulin users with diabetes. Tandem has strategic development and commercialization partnerships with leading companies such as Dexcom, Inc. and Abbott Laboratories. Established in 2006 and headquartered in San Diego, California, the company was initially known as Phluid Inc. before rebranding as Tandem Diabetes Care, Inc. in January 2008.
Show more...
FAQ
What is Tandem Diabetes Care stock price today?▼
The current price of TNDM is $16.71 USD — it has increased by +0.66% in the past 24 hours. Watch Tandem Diabetes Care stock price performance more closely on the chart.
What is Tandem Diabetes Care stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Tandem Diabetes Care stocks are traded under the ticker TNDM.
Is Tandem Diabetes Care stock price growing?▼
TNDM stock has fallen by -9.1% compared to the previous week, the month change is a +30.97% rise, over the last year Tandem Diabetes Care has showed a -19.12% decrease.
What is Tandem Diabetes Care market cap?▼
Today Tandem Diabetes Care has the market capitalization of 1.14B
When is the next Tandem Diabetes Care earnings date?▼
Tandem Diabetes Care is going to release the next earnings report on August 05, 2026.
What were Tandem Diabetes Care earnings last quarter?▼
TNDM earnings for the last quarter are -0.3 USD per share, whereas the estimation was -0.44 USD resulting in a +32.8% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Tandem Diabetes Care revenue for the last year?▼
Tandem Diabetes Care revenue for the last year amounts to 2.03B USD.
What is Tandem Diabetes Care net income for the last year?▼
TNDM net income for the last year is -409.42M USD.
How many employees does Tandem Diabetes Care have?▼
As of June 15, 2026, the company has 2,650 employees.
In which sector is Tandem Diabetes Care located?▼
Tandem Diabetes Care operates in the Health & Wellness sector.
When did Tandem Diabetes Care complete a stock split?▼
The last stock split for Tandem Diabetes Care was on October 10, 2017 with a ratio of 1:10.
Where is Tandem Diabetes Care headquartered?▼
Tandem Diabetes Care is headquartered in San Diego, United States.